{"slideshow_credits": null, "snippet": "The drug, Tecentriq from Roche, works by using the body\u2019s immune system against tumors, and is the first drug of its type approved for bladder cancer.", "abstract": "Food and Drug Administration approves Roche's new immunotherapy drug, Tecentriq, to treat bladder cancer; drug belongs to class of medicines called checkpoint inhibitors.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/05/19/business/food-and-drug-administration-immunotherapy-bladder-cancer.html", "lead_paragraph": "The drug, Tecentriq from Roche, works by using the body\u2019s immune system against tumors, and is the first drug of its type approved for bladder cancer.", "headline": {"main": "F.D.A. Approves an Immunotherapy Drug for Bladder Cancer", "print_headline": "F.D.A. Approves Immunotherapy Drug for Treatment of Bladder Cancer"}, "_id": "573ccd9338f0d81236fa7ee1", "word_count": "1008", "multimedia": [{"height": 126, "url": "images/2016/05/19/business/19IMMUNE/19IMMUNE-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/05/19/business/19IMMUNE/19IMMUNE-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 961, "url": "images/2016/05/19/business/19IMMUNE/19IMMUNE-articleLarge.jpg", "legacy": {"xlarge": "images/2016/05/19/business/19IMMUNE/19IMMUNE-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "961"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/05/19/business/19IMMUNE/19IMMUNE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/05/19/business/19IMMUNE/19IMMUNE-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-05-19T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Roche Holding AG", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Bladder Cancer", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Immune System", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}